Effect of new bioactive substances obtained from possible probiotic bacteria on miRNA expression by in vitro cocultivation in colorectal cancer cells.
1/5 보강
In our study, were evaluated effect on colorectal cancer cells of possible probiotic bacteria and new bioactive substances (paraprobiotics/postbiotics), miRNA-expression.
APA
Avcı E, Avcı GA (2025). Effect of new bioactive substances obtained from possible probiotic bacteria on miRNA expression by in vitro cocultivation in colorectal cancer cells.. International journal of environmental health research, 35(12), 3713-3722. https://doi.org/10.1080/09603123.2025.2495195
MLA
Avcı E, et al.. "Effect of new bioactive substances obtained from possible probiotic bacteria on miRNA expression by in vitro cocultivation in colorectal cancer cells.." International journal of environmental health research, vol. 35, no. 12, 2025, pp. 3713-3722.
PMID
40260513 ↗
Abstract 한글 요약
In our study, were evaluated effect on colorectal cancer cells of possible probiotic bacteria and new bioactive substances (paraprobiotics/postbiotics), miRNA-expression. strains, HT-29, and Caco-2 were used. The cytotoxicity of the biotics was determined by MTT and miRNA expression. In line with the data obtained, it was determined that probiotics had a proliferative effect on the fibroblast cell line and a cytotoxic effect on cancer cells. It was observed that paraprobiotics had a minimal effect compared to probiotics, postbiotics had a greater effect. In this work, the activities of new pharmabiotics are compared with living cells, eliminating the limitations of probiotics in terms of shelf life and viability, and thus allowing the creation of new commercial domestic and national products, which increases the unique value of our study. In addition, there will be safer alternatives for suppressed immune systems, and various disadvantages of probiotics can be eliminated.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.